GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock 0 06.05.2024 14:52 Fiercebiotech.com GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock ntaylor Mon, 05/06/2024 - 07:52
